Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance

R Kropp et al. Pneumonologie. 1976.

. 1976 Apr 9;153(2):109-17.

doi: 10.1007/BF02091432.

No abstract available

Similar articles

Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.
O'Mahony MG, Kar CW. O'Mahony MG, et al. Clin Allergy. 1973 Dec;3(4):353-62. doi: 10.1111/j.1365-2222.1973.tb01342.x. Clin Allergy. 1973. PMID: 4784489 No abstract available.
Rifampicin-dependent antibodies in twice-weekly treated patients.
Algeorge G, Rudescu D, Alexandrescu D. Algeorge G, et al. Scand J Respir Dis Suppl. 1973;84:98-101. Scand J Respir Dis Suppl. 1973. PMID: 4522081 No abstract available.
Clinical significance of precipitating anti-rifampicin antibodies.
Stevens E, Bloemmen J, Saerens E, Verbist L, Hellström PE, Mattson K, Fröseth B, Riska N. Stevens E, et al. Scand J Respir Dis Suppl. 1978;102:70-6. Scand J Respir Dis Suppl. 1978. PMID: 98841 No abstract available.
[Rifampicin therapy and circulating antibodies (author's transl)].
Bube FW, Reimers D. Bube FW, et al. Prax Pneumol. 1975 Oct;29(10):579-82. Prax Pneumol. 1975. PMID: 1208312 German. No abstract available.
The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis.
[No authors listed] [No authors listed] Tubercle. 1975 Sep;56(3):173-8. doi: 10.1016/0041-3879(75)90049-5. Tubercle. 1975. PMID: 766339 Clinical Trial. No abstract available.

Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection.
Moro RN, Mehaffy C, De P, Phillips E, Borisov AS, Sterling TR, Dobos KM. Moro RN, et al. J Infect Dis. 2024 Nov 15;230(5):1271-1278. doi: 10.1093/infdis/jiae180. J Infect Dis. 2024. PMID: 38640958 Free PMC article. Clinical Trial.